In a phase 2 trial, about half of cancer patients reported sustained reductions in depression and anxiety 2 years after a ...

A single dose of psilocybin provided sustained reductions in depression and anxiety among cancer patients diagnosed with ...

Electroconvulsive therapy (ECT) lowered the risk of death by suicide 34% among patients with severe depression, according to ...

A biotech company founded in Wales last year has raised $140mn in its first financing round to develop drugs for severe ...

New results from a clinical trial reveal that a single dose of psilocybin—a naturally occurring psychedelic compound found in ...

When we think of the symptoms of major depressive disorder (MDD) we typically think of persistent feelings of sadness, lack ...

New Zealand joins a growing list of countries exploring psychedelic-assisted therapy. In 2023, Australia became the first ...

New results from a clinical trial published by Wiley online in CANCER reveal that a single dose of psilocybin can provide sustained reductions in depression and anxiety in individuals with cancer ...

Major depressive disorder (MDD) is a mental health condition that negatively affects the mood of a person and causes a loss ...

Draig Therapeutics has been awarded £107m to advance the development of novel therapies for major neuropsychiatric disorders ...